These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis. Sheremata W; Cosgrove JB; Eylar EH N Engl J Med; 1974 Jul; 291(1):14-7. PubMed ID: 4598923 [No Abstract] [Full Text] [Related]
32. Cellular immunology in multiple sclerosis. A review through 1984. Baumhefner RW; Tourtellotte WW Concepts Immunopathol; 1985; 2():151-88. PubMed ID: 2439204 [No Abstract] [Full Text] [Related]
33. Oligodendrocytes: the putative target cells of multiple sclerosis. Abramsky O Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297 [No Abstract] [Full Text] [Related]
34. In vitro IgG synthesis by peripheral blood lymphocytes of multiple sclerosis patients and normal individuals. Effect of multiple sclerosis and non-multiple sclerosis brain antigens. Rastogi SC; Birkeboek NH Eur Neurol; 1983; 22(2):131-7. PubMed ID: 6840145 [TBL] [Abstract][Full Text] [Related]
35. [Encephalomyelitis disseminata: clinical aspects, pathogenesis and current therapy concepts]. Merkelbach S; Kölmel C; Schimrigk K Radiologe; 2000 Nov; 40(11):1036-44. PubMed ID: 11147319 [TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis and measles: a study of cellular sensitization. Field EJ; Shenton BK Eur Neurol; 1976; 14(6):401-7. PubMed ID: 991877 [TBL] [Abstract][Full Text] [Related]
37. [Experiences with the indirect Clausen Test using NTA as an antigen in multiple sclerosis and other neurologic diseases]. Dachsel R; Felber F; Liebert A Psychiatr Neurol Med Psychol (Leipz); 1984 Jun; 36(6):350-6. PubMed ID: 6484061 [TBL] [Abstract][Full Text] [Related]